212 results
8-K
EX-10.1
DRRX
Durect Corp
21 Jul 23
DURECT Corporation Announces $15 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
5:13pm
a Material Adverse Effect.
(q) Insurance. The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against
424B5
DRRX
Durect Corp
21 Jul 23
Prospectus supplement for primary offering
10:38am
to provide you with different information, and neither we nor the placement agent take any responsibility for any other information that others may give you … and is the responsibility of management. Our independent registered public accounting firm has not audited, reviewed, compiled or performed any procedures with respect
8-K
EX-10.1
907z2u9xl83w x6uzaq2
16 Jun 22
Departure of Directors or Certain Officers
5:01pm
8-K
ukj6o95kq22nh429
14 Dec 21
DURECT Corporation Expands Board of Directors with Appointment of Biopharmaceutical Industry Finance Veteran Peter Garcia
9:16am
8-K
EX-99.1
rcsvtlcjeubtx
14 Dec 21
DURECT Corporation Expands Board of Directors with Appointment of Biopharmaceutical Industry Finance Veteran Peter Garcia
9:16am